These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26873069)

  • 1. Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity.
    Alim Z; Beydemir Ş
    Chem Biol Drug Des; 2016 Aug; 88(2):188-96. PubMed ID: 26873069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo.
    Alici HA; Ekinci D; Beydemir S
    Clin Biochem; 2008 Nov; 41(16-17):1384-90. PubMed ID: 18640108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme:
    Alım Z; Kılıç D; Demir Y
    Arch Physiol Biochem; 2019 Dec; 125(5):387-395. PubMed ID: 29741961
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiepileptic drugs: Impacts on human serum paraoxonase-1.
    Beydemir Ş; Demir Y
    J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28032682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of some analgesics on paraoxonase-1 purified from human serum.
    Ekinci D; Beydemir S
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1034-9. PubMed ID: 19548782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium.
    Türkeş C; Söyüt H; Beydemir Ş
    J Enzyme Inhib Med Chem; 2015; 30(4):622-8. PubMed ID: 25519764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1).
    Demir Y; Köksal Z
    Pharmacol Rep; 2019 Jun; 71(3):545-549. PubMed ID: 31109643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternative purification method for human serum paraoxonase 1 and its interactions with sulfonamides.
    Ekinci D; Sentürk M; Beydemir S; Küfrevioğlu OI; Supuran CT
    Chem Biol Drug Des; 2010 Dec; 76(6):552-8. PubMed ID: 21040495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of human serum paraoxonase-1 with some respiratory drugs.
    Gökçe B; Sarıoğlu N; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22407. PubMed ID: 31581362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum.
    Türkeş C; Söyüt H; Beydemir Ş
    Environ Toxicol Pharmacol; 2016 Mar; 42():252-7. PubMed ID: 26915059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphenicol and macrolide derived antibiotics inhibit paraoxonase enzyme activity in human serum and human hepatoma cells (HepG2) in vitro.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biochemistry (Mosc); 2006 Jan; 71(1):46-50. PubMed ID: 16457617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I.
    Demir Y; Türkeş C; Beydemir Ş
    Anticancer Agents Med Chem; 2020; 20(7):887-896. PubMed ID: 32067621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1.
    Alim Z; Kilic D; Koksal Z; Beydemir S; Ozdemir H
    J Biochem Mol Toxicol; 2017 Oct; 31(10):. PubMed ID: 28665493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative purification method for human serum paraoxonase 1 and its interactions with anabolic compounds.
    Demir D; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016; 31(2):247-52. PubMed ID: 25792501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.
    Sinan S; Kockar F; Arslan O
    Biochimie; 2006 May; 88(5):565-74. PubMed ID: 16600468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative purification method for human serum paraoxonase 1 and its interaction with methidathion.
    Gençer N; Yavuz E
    Arch Physiol Biochem; 2017 Jul; 123(3):159-164. PubMed ID: 28276711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of PON1 from human serum and assessment of enzyme kinetics against metal toxicity.
    Ekinci D; Beydemir S
    Biol Trace Elem Res; 2010 Jun; 135(1-3):112-20. PubMed ID: 19727574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biol Pharm Bull; 2006 Aug; 29(8):1559-63. PubMed ID: 16880604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.